DFFN Annual ROE
-77.12%
-8.10%-11.74%
31 December 2022
Summary:
As of January 30, 2025, DFFN annual return on equity is -77.12%, with the most recent change of -8.10% (-11.74%) on December 31, 2022. During the last 3 years, it has fallen by -18.52% (-31.60%).DFFN ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
DFFN Quarterly ROE
-69.97%
-0.46%-0.66%
30 June 2023
Summary:
As of January 30, 2025, DFFN quarterly return on equity is -69.97%, with the most recent change of -0.46% (-0.66%) on June 30, 2023. Over the past year, it has increased by +4.89% (+6.53%).DFFN Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
DFFN ROE Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -11.7% | +6.5% |
| 3 y3 years | -31.6% | -20.7% |
| 5 y5 years | -1099.4% | -1931.7% |
DFFN ROE High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time | -100.5% | -102.3% |
Diffusion Pharmaceuticals ROE History
| Date | Annual | Quarterly |
|---|---|---|
| June 2023 | - | -69.97%(+0.7%) |
| Mar 2023 | - | -69.51%(+13.2%) |
| Dec 2022 | -77.12%(+11.7%) | -61.41%(+19.1%) |
| Sept 2022 | - | -51.58%(-31.1%) |
| June 2022 | - | -74.86%(+20.1%) |
| Mar 2022 | - | -62.35%(+14.4%) |
| Dec 2021 | -69.02%(+20.7%) | -54.50%(-8.0%) |
| Sept 2021 | - | -59.21%(+37.6%) |
| June 2021 | - | -43.02%(-7.4%) |
| Mar 2021 | - | -46.47%(-14.6%) |
| Dec 2020 | -57.17%(-2.4%) | -54.39%(-2.4%) |
| Sept 2020 | - | -55.70%(-3.9%) |
| June 2020 | - | -57.99%(-15.4%) |
| Mar 2020 | - | -68.57%(-8.8%) |
| Dec 2019 | -58.60%(-50.2%) | -75.17%(-19.6%) |
| Sept 2019 | - | -93.49%(-12.5%) |
| June 2019 | - | -106.83%(+15.2%) |
| Mar 2019 | - | -92.76%(+18.1%) |
| Dec 2018 | -117.67%(+1730.0%) | -78.55%(+76.9%) |
| Sept 2018 | - | -44.41%(-1262.6%) |
| June 2018 | - | 3.82%(-97.7%) |
| Mar 2018 | - | 163.90%(-389.4%) |
| Dec 2017 | -6.43%(-96.7%) | -56.64%(-106.0%) |
| Sept 2017 | - | 950.43%(-139.8%) |
| June 2017 | - | -2390.77%(+130.3%) |
| Mar 2017 | - | -1038.24%(+638.0%) |
| Dec 2016 | -196.38%(-101.2%) | -140.69%(-18.7%) |
| Sept 2016 | - | -172.99%(+51.5%) |
| June 2016 | - | -114.22%(+64.6%) |
| Mar 2016 | - | -69.41%(+122.3%) |
| Dec 2015 | 16.15 K%(<-9900.0%) | -31.22%(+7.0%) |
| Sept 2015 | - | -29.17%(-2.7%) |
| June 2015 | - | -29.97%(-14.9%) |
| Mar 2015 | - | -35.21%(-15.1%) |
| Dec 2014 | -37.61% | -41.46%(+7.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2014 | - | -38.46%(-33.5%) |
| June 2014 | - | -57.85%(-63.9%) |
| Mar 2014 | - | -160.28%(-527.0%) |
| Dec 2013 | -40.81%(-209.2%) | 37.54%(-134.8%) |
| Sept 2013 | - | -107.83%(-1.9%) |
| June 2013 | - | -109.90%(-249.7%) |
| Mar 2013 | - | 73.40%(-15.2%) |
| Dec 2012 | 37.36%(-73.5%) | 86.53%(-83.0%) |
| Sept 2012 | - | 508.37%(-42.5%) |
| June 2012 | - | 884.35%(-54.4%) |
| Mar 2012 | - | 1940.80%(-36.6%) |
| Dec 2011 | 141.19%(-104.3%) | 3061.39%(-885.6%) |
| Sept 2011 | - | -389.70%(-4.5%) |
| June 2011 | - | -408.25%(-67.9%) |
| Mar 2011 | - | -1272.96%(+36.6%) |
| Dec 2010 | -3273.53%(+348.8%) | -932.10%(+19.2%) |
| Sept 2010 | - | -781.83%(-0.1%) |
| June 2010 | - | -782.73%(-11.2%) |
| Mar 2010 | - | -881.52%(-10.3%) |
| Dec 2009 | -729.39%(+53.0%) | -982.58%(-82.4%) |
| Sept 2009 | - | -5595.32%(+17.9%) |
| June 2009 | - | -4744.49%(-555.1%) |
| Mar 2009 | - | 1042.55%(+114.0%) |
| Dec 2008 | -476.83%(-7206.3%) | 487.07%(-663.5%) |
| Sept 2008 | - | -86.44%(+4.2%) |
| June 2008 | - | -82.96%(-9.3%) |
| Mar 2008 | - | -91.43%(-643.9%) |
| Dec 2007 | 6.71%(-80.1%) | 16.81%(-97.7%) |
| Sept 2007 | - | 726.11%(+45.6%) |
| June 2007 | - | 498.59%(+50.3%) |
| Mar 2007 | - | 331.66%(+422.3%) |
| Dec 2006 | 33.64%(-574.5%) | 63.50% |
| Dec 2005 | -7.09%(-96.4%) | - |
| Dec 1999 | -194.91%(-5454.7%) | - |
| Dec 1998 | 3.64% | - |
FAQ
- What is Diffusion Pharmaceuticals annual return on equity?
- What is the all time high annual ROE for Diffusion Pharmaceuticals?
- What is Diffusion Pharmaceuticals annual ROE year-on-year change?
- What is Diffusion Pharmaceuticals quarterly return on equity?
- What is the all time high quarterly ROE for Diffusion Pharmaceuticals?
- What is Diffusion Pharmaceuticals quarterly ROE year-on-year change?
What is Diffusion Pharmaceuticals annual return on equity?
The current annual ROE of DFFN is -77.12%
What is the all time high annual ROE for Diffusion Pharmaceuticals?
Diffusion Pharmaceuticals all-time high annual return on equity is 16.15 K%
What is Diffusion Pharmaceuticals annual ROE year-on-year change?
Over the past year, DFFN annual return on equity has changed by -8.10% (-11.74%)
What is Diffusion Pharmaceuticals quarterly return on equity?
The current quarterly ROE of DFFN is -69.97%
What is the all time high quarterly ROE for Diffusion Pharmaceuticals?
Diffusion Pharmaceuticals all-time high quarterly return on equity is 3061.39%
What is Diffusion Pharmaceuticals quarterly ROE year-on-year change?
Over the past year, DFFN quarterly return on equity has changed by +4.89% (+6.53%)